Marc Wilson has served as our Chief Financial Officer since January 2018. Prior to Crinetics, Mr. Wilson was Vice President of Finance and Accounting and Chief Accounting Officer at Cidara Therapeutics, Inc., from September 2014 to January 2018. From 2010 to 2014, Mr. Wilson was Director of Accounting and Controller at Trius Therapeutics, until its acquisition by Cubist Pharmaceuticals. Prior to Trius, Mr. Wilson worked at Neurocrine Biosciences, Inc. from 2007 to 2010. Mr. Wilson began his career with PricewaterhouseCoopers LLP and is a certified public accountant.
Mr. Wilson earned a bachelor’s degree in Economics and Accounting from the College of the Holy Cross.